Low Testosterone Therapy is Causing Serious Adverse Reactions

June 2nd, 2014

Testosterone lawsuits are being filed throughout the country.  The Yost Legal Group defective drugs lawyers are actively investigating testosterone lawsuits for heart attack, stroke, pulmonary embolism and death. Reliable scientific studies confirm Testosterone supplementation dramatically increases the risk of these side effects in men who are healthy or have a prior heart condition. If your loved one has suffered heart attack, stroke, blood clot or death after initiating testosterone therapy, call the experienced testosterone lawyers at the Yost Legal Group about filing a testosterone lawsuit.


A recent scientific study has confirmed that men over age 65, and younger men with a history of heart ailments, that use testosterone have a 200% to 300% increased risk of heart attack and stroke.  These side effects are believed to be caused by the increased production of red blood cells leading to thickening of the blood and blood clots. When blood clots break loose and travel to the heart they become lodged in the small vasculature in the lungs causing pulmonary embolism. Pulmonary embolism can lead to heart attack, stroke, and death. Often the first side effect of testosterone use is death caused by heart attack, stroke or pulmonary embolism.

Some of the testosterone users who survive heart attack, stroke, or pulmonary embolism have serious side effects including:

◦                     complete disability from work

◦                     partial paralysis

◦                     memory loss

◦                     slurred speech

Some men require a lifetime of care as a result of their testosterone related injuries.


The manufacturers of testosterone supplementation knew that only a very small number of men suffered from what is medically defined as low testosterone.  But they manufactured a demand for testosterone replacement therapy by putting out a message increase testosterone could increase libido, reduce fat, improve energy, and improve concentration. They even advertised a made up syndrome, “Low T.” Reliable studies show that over 25% of men prescribed testosterone did not even have a testosterone level check to see if they were being treated for a medical condition.  Many more were prescribed testosterone even though their tests did not show medically low testosterone.

The result was that men experiencing normal symptoms of aging asked their doctors to prescribe testosterone to reverse these symptoms.  Over 5 million prescriptions were written for testosterone replacement therapy last year.  Some of the products for testosterone are:

◦                     Androgel

◦                     Testopel

◦                     Axiron

◦                     Depo-testosterone

◦                     Testim

◦                     Striant

◦                     Fortesta

◦                     Bio-T-Gel

◦                     Androdurm

◦                     Delatestryl

Over 90 % of the prescriptions for testosterone were filled with Androgel, Axiron, Testim , or Fortesta. Testosterone is still on the market today.


One of the most important things you will do in your low testosterone lawsuit is selecting the right attorney.  It is important to hire a defective drug lawyer who has experience handling class action lawsuits and defective drug lawsuits.  We at the Yost Legal Grouphave extensive experience representing the injured victims of defective drugs.  We secured compensation for hundreds of injured defective pharmaceutical drug users in multi-district litigation and class actions.  Contact us today for a free initial consultation.

If we take your case we will do so on a no win/no fee or expense basis only.  That means you do not pay a fee expense unless you recover.  If you or a loved one has suffered stroke, heart attack, pulmonary embolism or death after use of a brand name testosterone product, call 1-800-YOSTLAW (1-800-967-8529) to speak to one of our attorneys today.

AbbVie Hit with $150M Verdict in “Low-T” Trial

The first jury verdict in a series of bellwether trials involving the testosterone treatment AndroGel is in. The jury found that the manufacturer of the gel, AbbVie, should pay $150 million in punitive damages to Oregon resident Jesse Mitchell. After seeing a commercial about AndroGel and using the product for 4 years, Mr. Mitchell suffered a nearly fatal heart attack. He testified that he would not have used the drug if AbbVie had properly warned…

Read More »

First Testosterone Gel Trial to Begin in June

The first of seven multidistrict litigation (MDL) trials involving testosterone therapy gel products begins on June 5, 2017 in the U.S District Court for the Northern District of Illinois.  About 7,000 individual cases have been filed in this MDL. The Plaintiffs allege that over a dozen pharmaceutical companies unethically and aggressively marketed testosterone replacement therapy drugs to treat symptoms of normal male aging. AbbVie Inc. and Abbott Laboratories face most of the claims in the…

Read More »

FDA Announces Labeling Change for Low Testosterone Medications; Warns of Increased Risk of Heart Attack and Stroke with Use

The Food and Drug Administration (FDA) recently announced that they will be increasing restrictions on the labeling and sale of medication aimed at treating low levels of testosterone in adult men. For years, drug manufacturers have marketed medications such as Androgel, Axiron, and many others, as a “cure” for many of the symptoms associated with the normal aging process of adult men. According to these advertisements, problems such as lowered libido, erectile dysfunction, decreased energy…

Read More »

European Union Agrees with FDA, Testosterone Therapy Is Too Risky for All defective drug lawyers baltimore, product liability, medical malpractice lawyers maryland, low testosterone therapy

The leading Medical Associations in the United States and European Union have reached a consensus on therapies promising to treat low levels of testosterone in older men, a condition also known as “Low-T.” The U.S Food and Drug Administration (FDA) has already issued warnings about the use of Testosterone therapy treatments, advising consumers that the medications significantly raise the risk of serious blood clot and cardiac conditions. The European Union’s European Medicines Agency (EMA) reached…

Read More »